PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 26971407-9 2016 The combination of IL-1beta and already used therapies, i.e. IFNalpha or tenofovir, demonstrated a stronger or similar anti-HBV activity. Tenofovir 73-82 interleukin 1 beta Homo sapiens 19-27